Cargando…
Molecular docking to explore the possible binding mode of potential inhibitors of thioredoxin glutathione reductase
Praziquantel (PZQ) is the treatment of choice for schistosomiasis, one of the most important but neglected tropical diseases. Recently, however, Schistosoma have exhibited reduced susceptibility to PZQ, and an urgent need to develop new drugs to treat schistosomiasis has emerged. Thioredoxin glutath...
Autores principales: | HUANG, JINGWEI, HUA, WEIJUAN, LI, JIAHUANG, HUA, ZICHUN |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4581810/ https://www.ncbi.nlm.nih.gov/pubmed/26239395 http://dx.doi.org/10.3892/mmr.2015.4119 |
Ejemplares similares
-
Thioredoxin Glutathione Reductase as a Novel Drug Target: Evidence from Schistosoma japonicum
por: Song, LiJun, et al.
Publicado: (2012) -
Cheminformatics Models for Inhibitors of Schistosoma mansoni Thioredoxin Glutathione Reductase
por: Gaba, Sonam, et al.
Publicado: (2014) -
Identification of Thioredoxin Glutathione Reductase Inhibitors That Kill Cestode and Trematode Parasites
por: Ross, Fabiana, et al.
Publicado: (2012) -
Non-covalent inhibitors of thioredoxin glutathione reductase with schistosomicidal activity in vivo
por: Petukhova, Valentina Z., et al.
Publicado: (2023) -
Identification of Peptide Antagonists to Thioredoxin Glutathione Reductase of Schistosoma japonicum
por: Song, Li-Jun, et al.
Publicado: (2018)